GLP-1 and Hair Loss: Why Ozempic and Wegovy Cause Shedding and What to Do About It

Hair loss is one of the most commonly reported side effects among people starting GLP-1 medications like Ozempic, Wegovy, and Zepbound. It is also one of the most misunderstood.

The good news: in most cases, the hair loss is not caused by the medication itself. The bad news: it is real, it is temporary, and there are things you can do to minimize it.

What Is Actually Happening

The hair loss most GLP-1 users experience is a condition called telogen effluvium. It is not the drug stripping follicles of their function — it is a normal biological response to rapid weight loss and caloric restriction.

Here is the mechanism: hair grows in cycles. At any given time, roughly 85–90% of follicles are in the active growth phase (anagen) and 10–15% are in the resting phase (telogen), after which hairs fall out and new ones grow in. When the body experiences significant physiological stress — rapid weight loss, surgery, illness, nutritional deficiency, or childbirth — a larger than normal percentage of follicles shift prematurely into the resting phase. Two to four months later, those hairs fall out all at once.

The result is diffuse shedding across the entire scalp, typically noticed as hair coming out in larger amounts during washing and brushing. It can look alarming. But it is not permanent hair loss — the follicles are still alive and will regrow hair once the physiological stress resolves.

The Data From GLP-1 Trials

Hair loss (alopecia) was reported in approximately 3% of participants in the STEP trials for semaglutide 2.4 mg (Wegovy), compared to about 1% in the placebo group. The placebo group was also on a calorie-reduced diet, which itself can trigger telogen effluvium — explaining why the difference is smaller than many expect.

Tirzepatide trials (SURMOUNT program) showed similar rates. Hair loss was more common in participants who lost weight more rapidly and in those with greater total weight loss — consistent with the telogen effluvium explanation rather than direct drug toxicity.

Importantly: in follow-up data, most patients saw hair density return to baseline without stopping medication. The shedding phase is typically self-limiting within 3–6 months.

Why GLP-1 Medications Get Blamed Specifically

Rapid weight loss is the most common trigger of telogen effluvium in healthy adults. GLP-1 medications produce faster and greater weight loss than most people have experienced before — which means they also produce more pronounced telogen effluvium than most people have experienced before.

The timing is convincing: you start a new medication, you lose weight rapidly, your hair starts falling out 2–4 months later. The medication feels like the obvious culprit. But the actual culprit is the weight loss and caloric deficit that the medication is producing — not the drug itself directly.

This distinction matters because it changes the approach. If the drug were the direct cause, stopping it might help. Since the mechanism is nutritional stress, stopping the drug and regaining the weight would eventually resolve the hair loss — but so would continuing the drug and addressing the nutritional factors.

What You Can Do About It

Protein intake is the most important variable. Hair is made of keratin, a protein. Rapid weight loss combined with insufficient protein is the fastest path to significant telogen effluvium. GLP-1 medications reduce appetite dramatically, which means many patients unintentionally reduce their protein intake at the same time they are losing weight rapidly. This is the combination that drives the worst hair loss outcomes.

Target 0.7–1.0 grams of protein per pound of goal body weight daily. On a reduced-calorie GLP-1 diet, this requires intentional effort — prioritizing protein-dense foods (eggs, Greek yogurt, chicken, fish, legumes) and considering a protein supplement if whole-food sources are insufficient given your reduced appetite.

Micronutrient monitoring matters. Iron deficiency, zinc deficiency, and biotin deficiency all independently contribute to hair loss. GLP-1 medications reduce food volume, which can create micronutrient gaps if diet quality is not actively managed. A blood panel including ferritin, zinc, and complete metabolic panel at 3–6 months on GLP-1 therapy is reasonable for anyone experiencing significant hair loss.

Slow the weight loss pace if needed. Faster is not always better. Patients losing more than 2 pounds per week for extended periods are putting more physiological stress on their hair follicles than patients losing 0.5–1 pound per week. Working with your provider on dose titration to target sustainable weight loss pace (1–1.5 lbs/week) can reduce telogen effluvium severity.

Topical minoxidil can accelerate recovery. Over-the-counter minoxidil (Rogaine) shortens the telogen phase and pushes follicles back into active growth sooner. It does not address the underlying cause, but it can meaningfully shorten the duration of visible shedding. It is available without a prescription and is safe to use alongside GLP-1 medications.

When to Talk to a Dermatologist

Most GLP-1-related hair loss resolves on its own within 6 months. See a dermatologist if:

• Shedding continues beyond 6 months without improvement
• You notice patchy hair loss rather than diffuse shedding (which suggests a different diagnosis)
• Hair loss is accompanied by scalp tenderness, redness, or scaling
• You have a personal or family history of androgenetic alopecia (pattern baldness)

Women with PCOS or thyroid conditions may experience hair loss from multiple overlapping causes when starting GLP-1 therapy. Thyroid function testing is worth adding to the workup if hair loss is severe.

The Bottom Line

Hair loss on GLP-1 medications is real, common, and almost always temporary. It is driven by the weight loss and caloric deficit, not by direct follicle toxicity. The most effective preventive measure is adequate protein intake throughout your treatment. Most patients see full recovery within 3–6 months without stopping their medication.

If you are considering starting GLP-1 treatment and are concerned about this side effect, the evidence strongly supports continuing treatment while managing protein intake — not avoiding treatment to protect your hair. The health benefits of achieving and maintaining a healthy weight substantially outweigh the temporary cosmetic impact of telogen effluvium.

Remedy Meds offers physician-supervised GLP-1 programs with ongoing provider access. A provider who knows your history can help you navigate side effects like hair loss and adjust your approach as needed. Learn more at remedymeds.co.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider for personalized guidance. Last updated: March 2026.